S颗粒呈递轮状病毒VP8*疫苗在小鼠中的免疫应答与保护效力
本研究在小鼠轮状病毒攻击模型中评价S-VP8*纳米颗粒疫苗。构建含鼠轮状病毒EDIM株VP8*抗原的S-mVP8*并免疫小鼠,诱导高滴度抗EDIM VP8* IgG;与未免疫对照相比,S-mVP8*对同源EDIM攻击的保护效力达97%(基于粪便排毒减少)。结果支持多价S-VP8*纳米颗粒作为轮状病毒候选疫苗。
要点
- S-mVP8*免疫小鼠诱导高滴度抗EDIM VP8* IgG。
- 同源EDIM攻击后,S-mVP8*基于粪便排毒减少的保护效力为97%。
- 结果支持多价S-VP8*纳米颗粒作为轮状病毒候选疫苗。
核心结论
- S-mVP8*纳米颗粒疫苗在小鼠同源轮状病毒攻击模型中显示高保护效力,支持其作为轮状病毒候选疫苗进一步开发。
研究设计与样本
- 研究为小鼠免疫与轮状病毒攻击模型,构建含鼠轮状病毒EDIM株VP8*抗原的S-mVP8*纳米颗粒疫苗并免疫小鼠。
主要发现
- S-mVP8*免疫小鼠产生高滴度抗EDIM VP8* IgG。
- 与未免疫对照相比,S-mVP8*对同源EDIM轮状病毒攻击基于粪便排毒减少的保护效力为97%。
关键数值与推荐
- 保护效力97%为基于粪便排毒减少、针对同源EDIM株攻击、与未免疫对照比较的结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rotaviruses cause severe diarrhea in infants and young children, leading to significant morbidity and mortality. Despite implementation of current rotavirus vaccines, severe diarrhea caused by rotaviruses still claims ∼200,000 lives of children with great economic loss worldwide each year. Thus, new prevention strategies with high efficacy are highly demanded. Recently, we have developed a polyvalent protein nanoparticle derived from norovirus VP1, the S particle, and applied it to display rotavirus neutralizing antigen VP8* as a vaccine candidate (S-VP8*) against rotavirus, which showed promise as a vaccine based on mouse immunization and in vitro neutralization studies. Here we further evaluated this S-VP8* nanoparticle vaccine in a mouse rotavirus challenge model. S-VP8* vaccines containing the murine rotavirus (EDIM strain) VP8* antigens (S-mVP8*) were constructed and immunized mice, resulting in high titers of anti-EDIM VP8* IgG. The S-mVP8* nanoparticle vaccine protected immunized mice against challenge of the homologous murine EDIM rotavirus at a high efficacy of 97% based on virus shedding reduction in stools compared with unimmunized controls. Our study further supports the polyvalent S-VP8* nanoparticles as a promising vaccine candidate against rotavirus and warrants further development.
引用
- Xia M, Huang P, Jiang X, et al. Immune response and protective efficacy of the S particle presented rotavirus VP8* vaccine in mice. Vaccine. 2019. PMID: 31201052. doi:10.1016/j.vaccine.2019.05.075
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。